On May 4, 2020, DNA Genotek, a subsidiary of OraSure Technologies, announced that its ORAcollect RNA kit (OR-100) was included as the collection device for anterior nares (nasal) samples under a FDA Emergency Use Authorization granted to Biocerna for its PCR-based SARS-CoV-2 assay.